J. Bommer

2.4k total citations
31 papers, 1.7k citations indexed

About

J. Bommer is a scholar working on Nephrology, Surgery and Hematology. According to data from OpenAlex, J. Bommer has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 6 papers in Surgery and 6 papers in Hematology. Recurrent topics in J. Bommer's work include Dialysis and Renal Disease Management (10 papers), Parathyroid Disorders and Treatments (5 papers) and Erythropoietin and Anemia Treatment (5 papers). J. Bommer is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Parathyroid Disorders and Treatments (5 papers) and Erythropoietin and Anemia Treatment (5 papers). J. Bommer collaborates with scholars based in Germany, United States and Japan. J. Bommer's co-authors include Christian Combe, Rajiv Saran, Glenn M. Chertow, H. Hölzer, Paolo Raggi, Steven K. Burke, Scott Chasan-Taber, Friedrich K. Port, Francesco Locatelli and T. Akiba and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

J. Bommer

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Bommer Germany 15 1.3k 406 343 306 196 31 1.7k
A. M. Brownjohn United Kingdom 22 1.3k 1.0× 288 0.7× 436 1.3× 205 0.7× 89 0.5× 58 1.8k
P. Naish United Kingdom 19 1.2k 0.9× 181 0.4× 602 1.8× 248 0.8× 183 0.9× 58 2.0k
Naoki Kimata Japan 22 1.3k 1.0× 195 0.5× 394 1.1× 461 1.5× 203 1.0× 56 2.1k
E. Lars Penne Netherlands 25 1.3k 1.0× 322 0.8× 600 1.7× 507 1.7× 175 0.9× 48 1.8k
James A. Sloand United States 24 1.1k 0.9× 323 0.8× 257 0.7× 313 1.0× 231 1.2× 73 2.4k
David Van Wyck United States 14 999 0.8× 536 1.3× 272 0.8× 156 0.5× 163 0.8× 31 1.6k
Ezio Movilli Italy 27 1.5k 1.1× 362 0.9× 514 1.5× 471 1.5× 450 2.3× 54 2.1k
A. De Vecchi Italy 16 908 0.7× 189 0.5× 272 0.8× 300 1.0× 57 0.3× 41 1.4k
James Ebben United States 14 1.3k 1.0× 400 1.0× 247 0.7× 491 1.6× 162 0.8× 23 1.8k
Norio Hanafusa Japan 26 974 0.8× 235 0.6× 383 1.1× 164 0.5× 164 0.8× 138 2.0k

Countries citing papers authored by J. Bommer

Since Specialization
Citations

This map shows the geographic impact of J. Bommer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bommer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bommer more than expected).

Fields of papers citing papers by J. Bommer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bommer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bommer. The network helps show where J. Bommer may publish in the future.

Co-authorship network of co-authors of J. Bommer

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bommer. A scholar is included among the top collaborators of J. Bommer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bommer. J. Bommer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bommer, J., et al.. (2015). Treatment of Polytransfused Hemodialysis Patients with Recombinant Human Erythropoietin. Contributions to nephrology. 131–138.
2.
Bommer, J., et al.. (2015). rhEPO Treatment of Anemia in Uremic Patients. Contributions to nephrology. 87. 59–67.
3.
Bommer, J., et al.. (2015). Variations of Recombinant Human Erythropoietin Application in Hemodialysis Patients. Contributions to nephrology. 76. 149–158.
4.
5.
Tentori, Francesca, S. J. Elder, Jyothi R. Thumma, et al.. (2010). Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrology Dialysis Transplantation. 25(9). 3050–3062. 217 indexed citations
6.
Heinrich, T., Verena Häfner, H. Schmidt-Gayk, et al.. (2008). Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function. Nephrology Dialysis Transplantation. 23(9). 2861–2867. 11 indexed citations
7.
Ritz, E., J. Bommer, & M. Zeier. (2008). β2-Mikroglobulin-bedingte Amyloidose: Eine neue Komplikation der Langzeit-Hämodialyse. DMW - Deutsche Medizinische Wochenschrift. 113(5). 190–196.
8.
Bailie, George R., S. J. Elder, Nancy A. Mason, et al.. (2007). Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrology Dialysis Transplantation. 22(4). 1163–1170. 25 indexed citations
9.
Saran, Rajiv, J.L. Bragg-Gresham, Nathan W. Levin, et al.. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney International. 69(7). 1222–1228. 380 indexed citations
10.
Chertow, Glenn M., Paolo Raggi, Scott Chasan-Taber, et al.. (2004). Determinants of progressive vascular calcification in haemodialysis patients. Nephrology Dialysis Transplantation. 19(6). 1489–1496. 231 indexed citations
11.
Brunkhorst, R., J. Bommer, Jonathan Braun, et al.. (2004). Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Nephrology Dialysis Transplantation. 19(5). 1224–1230. 59 indexed citations
12.
Locatelli, Francesco, R.L. Pisoni, Christian Combe, et al.. (2003). Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation. 19(1). 121–132. 348 indexed citations
13.
Bommer, J.. (2002). Prevalence and socio-economic aspects of chronic kidney disease. Nephrology Dialysis Transplantation. 17(suppl 11). 8–12. 64 indexed citations
14.
Locatelli, Francesco, Fernando Valderrábano, Nicholas A. Hoenich, et al.. (2000). Progress in dialysis technology: membrane selection and patient outcome. Nephrology Dialysis Transplantation. 15(8). 1133–1139. 19 indexed citations
15.
Kallinowski, B., Rezvan Ahmadi, Stefanie Seipp, J. Bommer, & Wolfgang Stremmel. (1998). Clinical impact of GB-C virus in haemodialysis patients. Nephrology Dialysis Transplantation. 13(1). 93–98. 14 indexed citations
16.
Feussner, Giso, J. Bommer, & R. Ziegler. (1990). Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis. Journal of Molecular Medicine. 68(2). 65–70. 8 indexed citations
17.
Bommer, J., et al.. (1987). No evidence for endotoxin transfer across high flux polysulfone membranes.. PubMed. 27(6). 278–82. 51 indexed citations
18.
Bommer, J., W. Tschöpe, Eberhard Ritz, & K. Andrássy. (1976). Sexual behaviour of hemodialyzed patients.. PubMed. 6(1). 315–8. 18 indexed citations
19.
Ritz, Ethan, et al.. (1975). [Bone changes in chronic renal insufficiency].. PubMed. 70(26). 1112–24. 1 indexed citations
20.
Andrássy, K., et al.. (1975). Thrombotischer Verschluß der (arteriovenösen) Cimino-Fistel bei akuter Pankreatitis. DMW - Deutsche Medizinische Wochenschrift. 100(12). 611–614. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Brownjohn Breakdown of academic impact, for papers by P. Naish Breakdown of academic impact, for papers by Naoki Kimata Breakdown of academic impact, for papers by E. Lars Penne Breakdown of academic impact, for papers by James A. Sloand Breakdown of academic impact, for papers by David Van Wyck Breakdown of academic impact, for papers by Ezio Movilli Breakdown of academic impact, for papers by A. De Vecchi Breakdown of academic impact, for papers by James Ebben Breakdown of academic impact, for papers by Norio Hanafusa
Rankless by CCL
2026